RecruitingNot ApplicableNCT04411823

Post-sleeve Gastrectomy Gastroesophageal Reflux Disease Prediction

Prediction of Post-laparoscopic Sleeve Gastrectomy Gastroesophageal Reflux Disease With an Endolumenal Functional Lumen Imaging Probe (EndoFLIP)

Sponsor

Mayo Clinic

Enrollment

200 participants

Start Date

Feb 1, 2021

Study Type

INTERVENTIONAL

Conditions

Gastroesophageal Reflux Sleeve Gastrectomy Bariatric Surgery Complication

Summary

Researchers are trying to identify predictors for gastroesophageal reflux disease after sleeve gastrectomy.

Eligibility

Min Age: 18 Years

Inclusion Criteria4

Adult patients \> 18 years
BMI 30 or greater kg/m2
Participants can give a consent to the procedure
Participants have no contraindications to LSG (gastric ulceration)

Exclusion Criteria4

Participants who have LA grade C or D esophagitis, Barrett mucosa or peptic stricture.
Patients who have evidence of a major motility abnormality defined by the Chicago classification version 3.0 (achalasia, absent contractility, esophagogastric junction outflow obstruction, distal esophageal spasm, or hypertensive peristalsis)
Patients with hiatal hernia \> 3 cm
Patients with previous esophageal or stomach surgery

Print for Your Doctor

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEEndoFLIP measurement

EndoFLIP device can measure gastroesophageal junction distensibility index and esophageal contractile pattern under FDA cleared indication. It is performed during endoscopy.

Locations(2)

Orlando Health

Orlando, Florida, United States

Mayo Clinic in Rochester

Rochester, Minnesota, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04411823

Related Trials

Impact of Foot Reflexology on Nausea After Obesity Surgery

NCT073132931 location

Study on Hydrotalcite for Relief of Acid Symptoms Due to Acid Rebound After Stopping Long-Term PPI Therapy

NCT072917002 locations